Clinical Trials Directory

Trials / Completed

CompletedNCT02839278

Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Centre Hospitalier Universitaire de Besancon · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to investigate in vitro the impact of a novel anti-inflammatory treatment on costimulatory molecules expressed on monocytes.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sample

Timeline

Start date
2015-04-01
Primary completion
2024-09-02
Completion
2024-09-02
First posted
2016-07-20
Last updated
2024-11-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02839278. Inclusion in this directory is not an endorsement.

Biological Evaluation of a Novel Anti-inflammatory Treatment in Immune-mediated Inflammatory Diseases (NCT02839278) · Clinical Trials Directory